MORENO-ARTERO, E.; MORICE-PICARD, Fanny; BREMOND-GIGNAC, D.; DRUMARE-BOUVET, I.; DUNCOMBE-POULET, C.; LECLERC-MERCIER, S.; DUFRESNE, H.; KAPLAN, J.; JOUANNE, B.; ARVEILER, Benoit; TAIEB, A.; HADJ-RABIA, S.

doi:10.1111/jdv.17275

Métadonnées

Afficher la notice complète

Licence d’utilisation du document

MORENO-ARTERO, E.

MORICE-PICARD, Fanny
Laboratoire Maladies Rares: Génétique et Métabolisme (Bordeaux) [U1211 INSERM/MRGM]

BREMOND-GIGNAC, D.

Langue

Article de revue

Ce document a été publié dans

Journal of the European Academy of Dermatology and Venereology. 2021-05-27, vol. 35, n° 7, p. 1449-1459

Résumé en anglais

Albinism is a worldwide genetic disorder caused by mutations in at least 20 genes, identified to date, that affect melanin production or transport in the skin, hair and eyes. Patients present with variable degrees of diffuse muco-cutaneous and adnexal hypopigmentation, as well as ocular features including nystagmus, misrouting of optic nerves and foveal hypoplasia. Less often, albinism is associated with blood, immunological, pulmonary, digestive and/or neurological anomalies. Clinical and molecular characterizations are essential in preventing potential complications. Disease-causing mutations remain unknown for about 25% of patients with albinism. These guidelines have been developed for the diagnosis and management of syndromic and non-syndromic forms of albinism, based on a systematic review of the scientific literature. These guidelines comprise clinical and molecular characterization, diagnosis, therapeutic approach and management.< Réduire

Métadonnées

Partager cette publication !

Licence d’utilisation du document

Management of albinism: French guidelines for diagnosis and care

Langue

Ce document a été publié dans

Résumé en anglais

URI

DOI

Unités de recherche